Grepafloxacin

Jump to: navigation, search
220px
Grepafloxacin
Systematic (IUPAC) name
1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline- 3-carboxylic acid
Identifiers
CAS number 119914-60-2
ATC code J01MA11
PubChem 72474
DrugBank APRD01003
Chemical data
Formula C19H22FN3O3 
Mol. mass 359.395 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 50%
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for

Grepafloxacin

Articles

Most recent articles on Grepafloxacin

Most cited articles on Grepafloxacin

Review articles on Grepafloxacin

Articles on Grepafloxacin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Grepafloxacin

Images of Grepafloxacin

Photos of Grepafloxacin

Podcasts & MP3s on Grepafloxacin

Videos on Grepafloxacin

Evidence Based Medicine

Cochrane Collaboration on Grepafloxacin

Bandolier on Grepafloxacin

TRIP on Grepafloxacin

Clinical Trials

Ongoing Trials on Grepafloxacin at Clinical Trials.gov

Trial results on Grepafloxacin

Clinical Trials on Grepafloxacin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Grepafloxacin

NICE Guidance on Grepafloxacin

NHS PRODIGY Guidance

FDA on Grepafloxacin

CDC on Grepafloxacin

Books

Books on Grepafloxacin

News

Grepafloxacin in the news

Be alerted to news on Grepafloxacin

News trends on Grepafloxacin

Commentary

Blogs on Grepafloxacin

Definitions

Definitions of Grepafloxacin

Patient Resources / Community

Patient resources on Grepafloxacin

Discussion groups on Grepafloxacin

Patient Handouts on Grepafloxacin

Directions to Hospitals Treating Grepafloxacin

Risk calculators and risk factors for Grepafloxacin

Healthcare Provider Resources

Symptoms of Grepafloxacin

Causes & Risk Factors for Grepafloxacin

Diagnostic studies for Grepafloxacin

Treatment of Grepafloxacin

Continuing Medical Education (CME)

CME Programs on Grepafloxacin

International

Grepafloxacin en Espanol

Grepafloxacin en Francais

Business

Grepafloxacin in the Marketplace

Patents on Grepafloxacin

Experimental / Informatics

List of terms related to Grepafloxacin


Grepafloxacin hydrochloride (Raxar®, Glaxo Wellcome) is an oral broad-spectrum quinoline antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn in the United States due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death.

th:เกรพพาฟลอกซาซิน



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox